{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:12:58Z","timestamp":1790957578461,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["R01HL09481806"],"award-info":[{"award-number":["R01HL09481806"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["855967"],"award-info":[{"award-number":["855967"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019592","name":"VA Connecticut Healthcare System West Haven VA Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jsbmb.2025.106676","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T02:33:00Z","timestamp":1736821980000},"page":"106676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Acute hyperglycemia induces podocyte apoptosis by monocyte TNF-\u03b1 release, a process attenuated by vitamin D and GLP-1 receptor agonists"],"prefix":"10.1016","volume":"247","author":[{"given":"Rong M.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisu","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burton M.","family":"Wice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Dusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Bernal-Mizrachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jsbmb.2025.106676_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcna.2012.10.001","article-title":"Epidemiology of diabetic kidney disease","volume":"97","author":"Reutens","year":"2013","journal-title":"Med Clin. North Am."},{"key":"10.1016\/j.jsbmb.2025.106676_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin. Pr."},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106676_bib3","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1053\/j.ajkd.2014.08.001","article-title":"Diabetic kidney disease: a report from an ADA Consensus Conference","volume":"64","author":"Tuttle","year":"2014","journal-title":"Am. J. Kidney Dis."},{"issue":"1 1","key":"10.1016\/j.jsbmb.2025.106676_bib4","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2011.11.015","article-title":"United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States","volume":"59","author":"Collins","year":"2012","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106676_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5414\/CN108027","article-title":"Relationship between the accuracy of glycemic markers and the chronic kidney disease stage in patients with type 2 diabetes mellitus","volume":"82","author":"Harada","year":"2014","journal-title":"Clin. Nephrol."},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106676_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3122\/jabfm.2011.04.100186","article-title":"Glycemic control patterns and kidney disease progression among primary care patients with diabetes mellitus","volume":"24","author":"Cummings","year":"2011","journal-title":"J. Am. Board Fam. Med"},{"key":"10.1016\/j.jsbmb.2025.106676_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/2040622319898370","article-title":"The variability of glycated hemoglobin is associated with renal function decline in patients with type 2 diabetes","volume":"11","author":"Lee","year":"2020","journal-title":"Ther. Adv. Chronic Dis."},{"issue":"44","key":"10.1016\/j.jsbmb.2025.106676_bib8","article-title":"Visit-to-visit glucose variability predicts the development of end-stage renal disease in type 2 diabetes: 10-year follow-up of Taiwan diabetes study","volume":"94","author":"Yang","year":"2015","journal-title":"Med. (Baltim. )"},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106676_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3181\/0705-MR-134","article-title":"Diabetic nephropathy: mechanisms of renal disease progression","volume":"233","author":"Kanwar","year":"2008","journal-title":"Exp. Biol. Med."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106676_bib10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1172\/JCI119163","article-title":"Podocyte loss and progressive glomerular injury in type II diabetes","volume":"99","author":"Pagtalunan","year":"1997","journal-title":"J. Clin. Invest"},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106676_bib11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.semnephrol.2007.01.006","article-title":"AGE, RAGE, and ROS in diabetic nephropathy","volume":"27","author":"Tan","year":"2007","journal-title":"Semin Nephrol."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106676_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2337\/diabetes.55.01.06.db05-0894","article-title":"Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy","volume":"55","author":"Susztak","year":"2006","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.jsbmb.2025.106676_bib13","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2337\/db08-1536","article-title":"Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases","volume":"58","author":"Eid","year":"2009","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.jsbmb.2025.106676_bib14","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/ndt\/gfw260","article-title":"Macrophages in diabetic nephropathy in patients with type 2 diabetes","volume":"32","author":"Klessens","year":"2017","journal-title":"Nephrol. Dial. Transpl."},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106676_bib15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1440-1797.2006.00576.x","article-title":"Macrophage accumulation in human progressive diabetic nephropathy","volume":"11","author":"Nguyen","year":"2006","journal-title":"Nephrology"},{"issue":"9","key":"10.1016\/j.jsbmb.2025.106676_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221991","article-title":"Macrophage phenotype and its relationship with renal function in human diabetic nephropathy","volume":"14","author":"Zhang","year":"2019","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jsbmb.2025.106676_bib17","doi-asserted-by":"crossref","first-page":"F1719","DOI":"10.1152\/ajprenal.00141.2013","article-title":"Macrophages directly mediate diabetic renal injury","volume":"305","author":"You","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.jsbmb.2025.106676_bib18","article-title":"Excessive activation of notch signaling in macrophages promote kidney inflammation, fibrosis, and necroptosis","volume":"13","author":"Ma","year":"2022","journal-title":"Front Immunol."},{"issue":"7","key":"10.1016\/j.jsbmb.2025.106676_bib19","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2337\/diab.45.7.954","article-title":"Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro","volume":"45","author":"Morohoshi","year":"1996","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106676_bib20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00011-010-0279-0","article-title":"Intermittent high glucose promotes expression of proinflammatory cytokines in monocytes","volume":"60","author":"Li-Bo","year":"2011","journal-title":"Inflamm. Res"},{"issue":"8","key":"10.1016\/j.jsbmb.2025.106676_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081892","article-title":"Repetitive Intermittent Hyperglycemia Drives the M1 polarization and inflammatory responses in THP-1 macrophages through the mechanism involving the TLR4-IRF5 pathway","volume":"9","author":"Al-Rashed","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106676_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2337\/dc10-1219","article-title":"The acute effect of clamped hyperglycemia on the urinary excretion of inflammatory cytokines\/chemokines in uncomplicated type 1 diabetes: a pilot study","volume":"34","author":"Cherney","year":"2011","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.jsbmb.2025.106676_bib23","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1161\/01.ATV.0000239488.05069.03","article-title":"Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta","volume":"26","author":"Azuma","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106676_bib24","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.dsx.2018.09.013","article-title":"The effects of vitamin D(3) supplementation on some metabolic and inflammatory markers in diabetic nephropathy patients with marginal status of vitamin D: a randomized double blind placebo controlled clinical trial","volume":"13","author":"Esfandiari","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106676_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.108.113159","article-title":"Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial","volume":"52","author":"Alborzi","year":"2008","journal-title":"Hypertension"},{"issue":"9752","key":"10.1016\/j.jsbmb.2025.106676_bib26","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","article-title":"Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial","volume":"376","author":"de Zeeuw","year":"2010","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jsbmb.2025.106676_bib27","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/jcb.10453","article-title":"Modulation of TNF-alpha expression in bone marrow macrophages: involvement of vitamin D response element","volume":"88","author":"Hakim","year":"2003","journal-title":"J. Cell Biochem"},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106676_bib28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/ndt\/gfu311","article-title":"The induction of C\/EBPbeta contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease","volume":"30","author":"Arcidiacono","year":"2015","journal-title":"Nephrol. Dial. Transpl."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106676_bib29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/10409231003628015","article-title":"ADAM-17: the enzyme that does it all","volume":"45","author":"Gooz","year":"2010","journal-title":"Crit. Rev. Biochem Mol. Biol."},{"issue":"17","key":"10.1016\/j.jsbmb.2025.106676_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21175978","article-title":"The iRhom2\/ADAM17 axis attenuates bacterial uptake by phagocytes in a cell autonomous manner","volume":"21","author":"Seifert","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"1-2","key":"10.1016\/j.jsbmb.2025.106676_bib31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jsbmb.2010.03.064","article-title":"Vitamin D inhibition of TACE and prevention of renal osteodystrophy and cardiovascular mortality","volume":"121","author":"Dusso","year":"2010","journal-title":"J. Steroid Biochem Mol. Biol."},{"issue":"9","key":"10.1016\/j.jsbmb.2025.106676_bib32","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1111\/dom.14776","article-title":"Effect of glucagon-like peptide 1 receptor agonists on albuminuria in adult patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"24","author":"Yuan","year":"2022","journal-title":"Diabetes Obes. Metab."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106676_bib33","first-page":"1789","article-title":"Glucagon\u2011like peptide\u20111 protects mouse podocytes against high glucose\u2011induced apoptosis, and suppresses reactive oxygen species production and proinflammatory cytokine secretion, through sirtuin 1 activation in vitro.","volume":"18","author":"Shi","year":"2018","journal-title":"Mol. Med Rep."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106676_bib34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrneph.2013.251","article-title":"The effect of RAAS blockade on the progression of diabetic nephropathy","volume":"10","author":"Roscioni","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jsbmb.2025.106676_bib35","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3389\/fendo.2018.00672","article-title":"Pleiotropic effects of GLP-1 and analogs on cell signaling, metabolism, and function","volume":"9","author":"Rowlands","year":"2018","journal-title":"Front Endocrinol."},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106676_bib36","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00125-010-2028-x","article-title":"Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes","volume":"54","author":"Kodera","year":"2011","journal-title":"Diabetologia"},{"issue":"5-6","key":"10.1016\/j.jsbmb.2025.106676_bib37","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/08977194.2015.1125349","article-title":"Exendin-4 attenuates renal tubular injury by decreasing oxidative stress and inflammation in streptozotocin-induced diabetic mice","volume":"33","author":"Sancar-Bas","year":"2015","journal-title":"Growth Factors"},{"issue":"6","key":"10.1016\/j.jsbmb.2025.106676_bib38","article-title":"GLP-1 receptor agonists and kidney protection","volume":"55","author":"Greco","year":"2019","journal-title":"Med. (Kaunas. )"},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106676_bib39","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.bbrc.2013.12.049","article-title":"Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes","volume":"443","author":"Kodera","year":"2014","journal-title":"Biochem Biophys. Res Commun."},{"issue":"10","key":"10.1016\/j.jsbmb.2025.106676_bib40","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1055\/s-0034-1371892","article-title":"Linagliptin blocks renal damage in type 1 diabetic rats by suppressing advanced glycation end products-receptor axis","volume":"46","author":"Nakashima","year":"2014","journal-title":"Horm. Metab. Res"},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106676_bib41","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bbrc.2012.07.086","article-title":"Glucagon-like peptide-1 (GLP-1) induces M2 polarization of human macrophages via STAT3 activation","volume":"425","author":"Shiraishi","year":"2012","journal-title":"Biochem Biophys. Res Commun."},{"issue":"7","key":"10.1016\/j.jsbmb.2025.106676_bib42","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.2337\/db11-1451","article-title":"Xenin-25 amplifies GIP-mediated insulin secretion in humans with normal and impaired glucose tolerance but not type 2 diabetes","volume":"61","author":"Wice","year":"2012","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106676_bib43","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1681\/ASN.V133630","article-title":"A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression","volume":"13","author":"Saleem","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"issue":"21","key":"10.1016\/j.jsbmb.2025.106676_bib44","doi-asserted-by":"crossref","first-page":"438","DOI":"10.21037\/atm.2016.08.53","article-title":"THP-1 cells as a model for human monocytes","volume":"4","author":"Bosshart","year":"2016","journal-title":"Ann. Transl. Med"},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106676_bib45","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1128\/IAI.66.3.1174-1180.1998","article-title":"Cell activation mediated by glycosylphosphatidylinositol-anchored or transmembrane forms of CD14","volume":"66","author":"Pugin","year":"1998","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.jsbmb.2025.106676_bib46","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.4049\/jimmunol.1102412","article-title":"Vitamin D inhibits monocyte\/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1","volume":"188","author":"Zhang","year":"2012","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106676_bib47","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/10715762.2014.997229","article-title":"Endoplasmic reticulum stress and Nrf2 repression in circulating cells of type 2 diabetic patients without the recommended glycemic goals","volume":"49","author":"Mozzini","year":"2015","journal-title":"Free Radic. Res"},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106676_bib48","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/db09-0659","article-title":"CD14+ monocytes are vulnerable and functionally impaired under endoplasmic reticulum stress in patients with type 2 diabetes","volume":"59","author":"Komura","year":"2010","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106676_bib49","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1210\/jc.2002-021025","article-title":"Monocyte NADPH oxidase subunit p22(phox) and inducible hemeoxygenase-1 gene expressions are increased in type II diabetic patients: relationship with oxidative stress","volume":"88","author":"Avogaro","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106676_bib50","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.diabres.2010.12.026","article-title":"Augmented NADPH oxidase activity and p22phox expression in monocytes underlie oxidative stress of patients with type 2 diabetes mellitus","volume":"91","author":"Huang","year":"2011","journal-title":"Diabetes Res Clin. Pr."},{"issue":"6","key":"10.1016\/j.jsbmb.2025.106676_bib51","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/HYPERTENSIONAHA.115.05344","article-title":"Role of epidermal growth factor receptor and endoplasmic reticulum stress in vascular remodeling induced by angiotensin II","volume":"65","author":"Takayanagi","year":"2015","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.jsbmb.2025.106676_bib52","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1007\/s001250100020","article-title":"Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence","volume":"44","author":"Bonora","year":"2001","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.jsbmb.2025.106676_bib53","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/CIRCRESAHA.120.316653","article-title":"Transient intermittent hyperglycemia accelerates atherosclerosis by promoting myelopoiesis","volume":"127","author":"Flynn","year":"2020","journal-title":"Circ. Res"},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106676_bib54","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41419-017-0217-y","article-title":"Glucagon-like peptide-1 receptor regulates endoplasmic reticulum stress-induced apoptosis and the associated inflammatory response in chondrocytes and the progression of osteoarthritis in rat","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jsbmb.2025.106676_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105969","article-title":"Glucagon-like peptide-1 receptor agonist exendin-4 mitigates lipopolysaccharide-induced inflammatory responses in RAW264.7 macrophages","volume":"77","author":"Lu","year":"2019","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.jsbmb.2025.106676_bib56","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2017.07.015","article-title":"Glucagon and glucagon-like peptide-1 as novel anti-inflammatory and immunomodulatory compounds","volume":"812","author":"Insuela","year":"2017","journal-title":"Eur. J. Pharm."},{"issue":"16","key":"10.1016\/j.jsbmb.2025.106676_bib57","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1161\/01.CIR.0000034509.14906.AE","article-title":"Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress","volume":"106","author":"Esposito","year":"2002","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.jsbmb.2025.106676_bib58","doi-asserted-by":"crossref","first-page":"17728","DOI":"10.1074\/jbc.275.23.17728","article-title":"Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways","volume":"275","author":"Guha","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.jsbmb.2025.106676_bib59","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.2337\/db08-0564","article-title":"High glucose induces toll-like receptor expression in human monocytes: mechanism of activation","volume":"57","author":"Dasu","year":"2008","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.jsbmb.2025.106676_bib60","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2337\/diabetes.48.6.1316","article-title":"Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo","volume":"48","author":"Ceolotto","year":"1999","journal-title":"Diabetes"},{"issue":"6065","key":"10.1016\/j.jsbmb.2025.106676_bib61","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1126\/science.1214400","article-title":"Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE","volume":"335","author":"Adrain","year":"2012","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.jsbmb.2025.106676_bib62","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1046\/j.1432-1033.2003.03606.x","article-title":"Tumor necrosis factor-alpha converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation","volume":"270","author":"Endres","year":"2003","journal-title":"Eur. J. Biochem"},{"issue":"31","key":"10.1016\/j.jsbmb.2025.106676_bib63","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1038\/onc.2011.522","article-title":"The unfolded protein response controls induction and activation of ADAM17\/TACE by severe hypoxia and ER stress","volume":"31","author":"Rzymski","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.jsbmb.2025.106676_bib64","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jsbmb.2013.10.016","article-title":"25(OH) vitamin D suppresses macrophage adhesion and migration by downregulation of ER stress and scavenger receptor A1 in type 2 diabetes","volume":"144 Pt A","author":"Riek","year":"2014","journal-title":"J. Steroid Biochem Mol. Biol."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106676_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054625","article-title":"Vitamin D deficiency induces high blood pressure and accelerates atherosclerosis in mice","volume":"8","author":"Weng","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106676_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/nu15030769","article-title":"Effects of vitamin D on cardiovascular risk and oxidative stress","volume":"15","author":"Renke","year":"2023","journal-title":"Nutrients"},{"issue":"37","key":"10.1016\/j.jsbmb.2025.106676_bib67","doi-asserted-by":"crossref","first-page":"32011","DOI":"10.1074\/jbc.M111.269118","article-title":"Molecular mechanism underlying 1,25-dihydroxyvitamin D regulation of nephrin gene expression","volume":"286","author":"Deb","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.jsbmb.2025.106676_bib68","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1111\/jcmm.13180","article-title":"Vitamin D3 ameliorates podocyte injury through the nephrin signalling pathway","volume":"21","author":"Trohatou","year":"2017","journal-title":"J. Cell Mol. Med"},{"issue":"9","key":"10.1016\/j.jsbmb.2025.106676_bib69","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00210-015-1124-3","article-title":"Exenatide (a GLP-1 agonist) improves the antioxidative potential of in vitro cultured human monocytes\/macrophages","volume":"388","author":"Buldak","year":"2015","journal-title":"Naunyn Schmiede Arch. Pharm."},{"issue":"10","key":"10.1016\/j.jsbmb.2025.106676_bib70","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.2337\/db11-1415","article-title":"Impaired MEK signaling and SERCA expression promote ER stress and apoptosis in insulin-resistant macrophages and are reversed by exenatide treatment","volume":"61","author":"Liang","year":"2012","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.jsbmb.2025.106676_bib71","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/CIRCULATIONAHA.109.856070","article-title":"1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus","volume":"120","author":"Oh","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jsbmb.2025.106676_bib72","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jsbmb.2012.12.019","article-title":"1,25(OH)2 vitamin D suppresses macrophage migration and reverses atherogenic cholesterol metabolism in type 2 diabetic patients","volume":"136","author":"Riek","year":"2013","journal-title":"J. Steroid Biochem Mol. Biol."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106676_bib73","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106676_bib74","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000334928","article-title":"Aberrant recruitment and activation of T cells in diabetic nephropathy","volume":"35","author":"Moon","year":"2012","journal-title":"Am. J. Nephrol."},{"issue":"14","key":"10.1016\/j.jsbmb.2025.106676_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147554","article-title":"Role of dendritic cell in diabetic nephropathy","volume":"22","author":"Kim","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.jsbmb.2025.106676_bib76","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1046\/j.1523-1755.2000.07710.x","article-title":"Cell cycle regulation in diabetic nephropathy","volume":"77","author":"Wolf","year":"2000","journal-title":"Kidney Int Suppl."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076025000044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076025000044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T08:34:46Z","timestamp":1774427686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076025000044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":76,"alternative-id":["S0960076025000044"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2025.106676","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute hyperglycemia induces podocyte apoptosis by monocyte TNF-\u03b1 release, a process attenuated by vitamin D and GLP-1 receptor agonists","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2025.106676","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106676"}}